eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all . Please read our guidelines before submitting your own eLetter.
Research ArticleHEALTH AND MEDICINE
Tumor-homing peptides as tools for targeted delivery of payloads to the placenta
- View ORCID ProfileAnna King1,2,
- View ORCID ProfileCornelia Ndifon1,2,
- View ORCID ProfileSylvia Lui1,2,
- Kate Widdows1,2,
- Venkata R. Kotamraju3,4,
- Lilach Agemy3,4,*,
- View ORCID ProfileTambet Teesalu3,4,†,
- View ORCID ProfileJocelyn D. Glazier1,2,
- Francesco Cellesi5,‡,
- Nicola Tirelli5,6,
- View ORCID ProfileJohn D. Aplin1,2,
- Erkki Ruoslahti3,4 and
- View ORCID ProfileLynda K. Harris1,2,5,§
- 1Maternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, Manchester M13 9WL, UK.
- 2Academic Health Science Centre, St Mary’s Hospital, Oxford Road, Manchester M13 9WL, UK.
- 3Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
- 4Center for Nanomedicine and Department of Molecular Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106–9610, USA.
- 5School of Pharmacy, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK.
- 6Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, University of Manchester, Manchester M13 9PT, UK.
- ↵§Corresponding author. Email: lynda.k.harris{at}manchester.ac.uk
↵* Present address: Weizmann Institute of Science, 234 Herzl Street, Rehovot 76100, Haifa, Israel.
↵† Present address: Laboratory of Cancer Biology, Institute of Biomedicine, Centre of Excellence for Translational Medicine, University of Tartu, Ravila 14b, 50411 Tartu, Estonia.
↵‡ Present address: Fondazione CEN-European Centre for Nanomedicine, Piazza Leonardo da Vinci 32, 20133 Milan, Italy; Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Pace 9, I-20122 Milan, Italy; and Dipartimento di Chimica, Materiali ed Ingegneria Chimica “G. Natta,” Politecnico di Milano, Via Mancinelli 7, 20131 Milan, Italy.
See allHide authors and affiliations
Science Advances 06 May 2016:
Vol. 2, no. 5, e1600349
DOI: 10.1126/sciadv.1600349
Vol. 2, no. 5, e1600349
DOI: 10.1126/sciadv.1600349
Anna King
1Maternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, Manchester M13 9WL, UK.
2Academic Health Science Centre, St Mary’s Hospital, Oxford Road, Manchester M13 9WL, UK.
Cornelia Ndifon
1Maternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, Manchester M13 9WL, UK.
2Academic Health Science Centre, St Mary’s Hospital, Oxford Road, Manchester M13 9WL, UK.
Sylvia Lui
1Maternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, Manchester M13 9WL, UK.
2Academic Health Science Centre, St Mary’s Hospital, Oxford Road, Manchester M13 9WL, UK.
Kate Widdows
1Maternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, Manchester M13 9WL, UK.
2Academic Health Science Centre, St Mary’s Hospital, Oxford Road, Manchester M13 9WL, UK.
Venkata R. Kotamraju
3Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
4Center for Nanomedicine and Department of Molecular Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106–9610, USA.
Lilach Agemy
3Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
4Center for Nanomedicine and Department of Molecular Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106–9610, USA.
Tambet Teesalu
3Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
4Center for Nanomedicine and Department of Molecular Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106–9610, USA.
Jocelyn D. Glazier
1Maternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, Manchester M13 9WL, UK.
2Academic Health Science Centre, St Mary’s Hospital, Oxford Road, Manchester M13 9WL, UK.
Francesco Cellesi
5School of Pharmacy, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK.
Nicola Tirelli
5School of Pharmacy, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK.
6Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, University of Manchester, Manchester M13 9PT, UK.
John D. Aplin
1Maternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, Manchester M13 9WL, UK.
2Academic Health Science Centre, St Mary’s Hospital, Oxford Road, Manchester M13 9WL, UK.
Erkki Ruoslahti
3Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
4Center for Nanomedicine and Department of Molecular Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106–9610, USA.
Lynda K. Harris
1Maternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, Manchester M13 9WL, UK.
2Academic Health Science Centre, St Mary’s Hospital, Oxford Road, Manchester M13 9WL, UK.
5School of Pharmacy, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK.
Submit a Response to This Article
No eLetters have been published for this article.